Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Institution of Clinical Sciences, Lund University, Lund, Sweden.
Ann Surg. 2021 Dec 1;274(6):e1202-e1208. doi: 10.1097/SLA.0000000000003800.
To investigate the prevalence and risk factors for permanent hypoparathyroidism after total thyroidectomy for benign disease in a population-based setting with data independent of input of complication data.
The reported rate of permanent hypoparathyroidism is highly variable and mostly rely on reported complication data from national or institutional registries.
All patients who underwent total thyroidectomy in Sweden from 2005 to 2015 were identified through Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery and the Swedish National Patient Register. Patients were matched to outcome data from the Swedish Prescribed Drug Register. Permanent hypoparathyroidism was defined as treatment with calcium and/or active vitamin D more than 1 year after surgery.
Seven thousand eight hundred fifty-two patients were included and 938 (12.5%) developed permanent hypoparathyroidism. The risk was lower in patients registered in the quality register (11.0% vs 16%, P < 0.001). In a multivariable analysis there was a higher risk of permanent hypoparathyroidism in patients with parathyroid autotransplantation [Odds ratio (OR) 1.72; 95% confidence interval 1.47-2.01], center-volume <100 thyroidectomies per year (OR 1.22; 1.03-1.44), age above 60 year (OR 1.64; 1.36-1.98) and female sex (OR 1.27; 1.05-1.54). Reported data from the quality register only identified 178 of all 938 patients with permanent hypoparathyroidism.
The risk of permanent hypoparathyroidism after total thyroidectomy was high and associated with parathyroid autotransplantation, higher age, female sex and surgery at a low volume center. Reported follow-up data might underestimate the rate of permanent hypoparathyroidism.
在一个基于人群的环境中,使用独立于并发症数据输入的数据,研究良性疾病全甲状腺切除术后永久性甲状旁腺功能减退症的患病率和危险因素。
永久性甲状旁腺功能减退症的报告率差异很大,主要依赖于国家或机构登记处报告的并发症数据。
通过斯堪的纳维亚甲状腺、甲状旁腺和肾上腺手术质量登记处和瑞典国家患者登记处,确定了 2005 年至 2015 年间在瑞典接受全甲状腺切除术的所有患者。将患者与瑞典处方药物登记处的结果数据相匹配。永久性甲状旁腺功能减退症的定义为手术后 1 年以上接受钙和/或活性维生素 D 治疗。
共纳入 7852 例患者,938 例(12.5%)发生永久性甲状旁腺功能减退症。质量登记处登记的患者风险较低(11.0%比 16%,P<0.001)。多变量分析显示,甲状旁腺自体移植患者永久性甲状旁腺功能减退症的风险更高[优势比(OR)1.72;95%置信区间 1.47-2.01],中心手术量<100 例/年(OR 1.22;1.03-1.44)、年龄>60 岁(OR 1.64;1.36-1.98)和女性(OR 1.27;1.05-1.54)。质量登记处报告的数据仅确定了所有 938 例永久性甲状旁腺功能减退症患者中的 178 例。
全甲状腺切除术后永久性甲状旁腺功能减退症的风险较高,与甲状旁腺自体移植、年龄较大、女性和手术量低的中心有关。报告的随访数据可能低估了永久性甲状旁腺功能减退症的发生率。